Figure 1.
CONSORT diagram of the AML1718 trial safety run-in and part 1. CRi, complete response without platelet and neutrophils recovery; PR, partial response; pts, patients; Rel, relapse; SCT, stem cell transplant; SD, stable disease.

CONSORT diagram of the AML1718 trial safety run-in and part 1. CRi, complete response without platelet and neutrophils recovery; PR, partial response; pts, patients; Rel, relapse; SCT, stem cell transplant; SD, stable disease.

or Create an Account

Close Modal
Close Modal